"You decide and we provide."
Cart 0

BRIEF-Amag submits supplemental NDA for makena auto-injector




reutersCOMPANYNEWS companyNews

* Amag submits supplemental new drug application to FDA for makena (hydroxyprogesterone caproate injection) auto-injector for subcutaneous use




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published